On June 30, 2022, Nicholas Khadder notified Standard BioTools Inc. (the Company) of his intention to resign from his position as Senior Vice President, General Counsel and Corporate Secretary, and from any and all other positions he holds as an officer or employee of the Company, in order to pursue another employment opportunity. Mr. Khadder's resignation is effective as of July 29, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.4 USD | -0.41% | -4.38% | +8.60% |
May. 08 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | Earnings Flash (LAB) STANDARD BIOTOOLS Reports Q1 Revenue $45.5M, vs. Street Est of $46M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.60% | 918M | |
+11.73% | 226B | |
+9.53% | 188B | |
+14.63% | 137B | |
+27.47% | 108B | |
-0.04% | 63.19B | |
+13.73% | 52.26B | |
+4.86% | 51B | |
+7.72% | 43.89B | |
+7.86% | 38.07B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Standard BioTools Inc. Announces Resignation of Nicholas Khadder as Senior Vice President, General Counsel and Corporate Secretary